Spectral Medical Inc.
TSX:EDT.TOMedical - Diagnostics & Research
-$0.02 today
- Market cap
- $306.00M
- Beta
- 0.23
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$0.13
Volume 0.02M
Average 0.06M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Spectral Medical Inc.
TSX:EDT.TO
Intrinsic Alpha fair value
Locked
Current Price
$1.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +13.6% | +141.1% (5yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +13.6% over three years. Forward estimates point to Revenue at +141.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Eupraxia Pharmaceuticals Inc. TSX:EPRX.TO | $783.37M | $11.65 | Not rated | -8.6 | +0.80% |
Kneat.com, Inc. TSX:KSI.TO | $624.86M | $6.50 | Overvalued | -73.0 | +57.77% |
Fennec Pharmaceuticals Inc. TSX:FRX.TO | $580.71M | $16.56 | Not rated | -36.5 | +58.04% |
Aurora Cannabis Inc. TSX:ACB.TO | $463.50M | $7.05 | Not rated | -3.2 | +3.95% |
Profound Medical Corp. TSX:PRN.TO | $388.24M | $10.60 | Not rated | -6.3 | +16.06% |
Canopy Growth Corporation TSX:WEED.TO | $364.19M | $0.81 | Not rated | -1.8 | -51.35% |
Cipher Pharmaceuticals Inc. TSX:CPH.TO | $360.13M | $14.17 | Undervalued | 9.3 | -3.33% |
Continue the stock analysis
Jump to another research area for this company.